Contact
      Please use this form to send email to PR contact of this press release:
      
      COVID-19 vaccine breakthrough
    
      TO:
      
      Sharen Pringle
      
      Vaxine Pty Ltd
      
      437 033 400
      
    
      Please use this form to send email to PR contact of this press release:
      
      COVID-19 vaccine breakthrough
    
      TO:
      
      Sharen Pringle
      
      Vaxine Pty Ltd
      
      437 033 400